Stockscreener 앱 받기
9.8949
1.28%
0.1249
Kura Oncology Inc 주식(KURA)의 최신 뉴스
Earnings call transcript: Kura Oncology Q3 2025 reports wider EPS loss - Investing.com
Kura Oncology (KURA) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com
Kura Oncology to present ziftomenib combination data at ASH meeting By Investing.com - Investing.com Australia
KURA Reports Lower Q3 Revenue, Focuses on Expanding Oncology Pip - GuruFocus
Kura Oncology: Q3 Earnings Snapshot - San Francisco Chronicle
Kura Oncology Eyes FDA Decision As Losses Mount And Optimism Grows - Finimize
Earnings Flash (KURA) Kura Oncology, Inc. Reports Q3 Revenue $20.8M, vs. FactSet Est of $18.9M - MarketScreener
Kura Oncology (KURA) Reports Q3 Earnings Miss - GuruFocus
Kura Oncology Inc Reports Q3 2025 Earnings: EPS Matches Estimates at -$0.85, Revenue Falls Short at $20.8 Million - GuruFocus
KURA ONCOLOGY Earnings Results: $KURA Reports Quarterly Earnings - Quiver Quantitative
Kura Oncology Q3 net loss widens to $74.1 mln - TradingView
Kura Oncology Highlights Progress with Ziftomenib for AML as FDA Review Continues and Phase 3 Trials Accelerate - Quiver Quantitative
BRIEF-Kura Oncology Q3 Collaboration Revenue USD 20.75 Million - TradingView
Kura Oncology Reports Third Quarter 2025 Financial Results - Bakersfield.com
Is Kura Oncology Inc. stock recession proofIPO Watch & Trade Opportunity Analysis - newser.com
AlphaQuest LLC Sells 29,555 Shares of Kura Oncology, Inc. $KURA - MarketBeat
How to monitor Kura Oncology Inc. with trend dashboardsMarket Performance Report & Verified Short-Term Plans - newser.com
Kura Oncology (KURA) Secures $30 Million Milestone Payment - GuruFocus
Kura Oncology receives second $30 million milestone payment from Kyowa Kirin - Investing.com
Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program with Kyowa Kirin - MarketScreener
Candlestick signals on Kura Oncology Inc. stock todayPortfolio Update Report & Breakout Confirmation Trade Signals - newser.com
Kura Oncology to present ziftomenib combination data at ASH meeting - Investing.com
Kura Oncology and Kyowa Kirin Announce Presentations of Ziftomenib Ven/Aza Combination Data in Frontline and Relapsed/Refractory NPM1-m or KMT2A-r Acute Myeloid Leukemia at 2025 ASH Annual Meeting - 富途牛牛
Why Kura Oncology Inc. stock attracts high net worth investorsWeekly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
What To Expect From Kura Oncology Inc (KURA) Q3 2025 Earnings - GuruFocus
Signal strength of Kura Oncology Inc. stock in tech scannersJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Is Kura Oncology (NASDAQ:KURA) Weighed On By Its Debt Load? - simplywall.st
How Kura Oncology Inc. stock reacts to Fed rate cutsPortfolio Profit Report & Expert Verified Movement Alerts - newser.com
Applying sector rotation models to Kura Oncology Inc.Weekly Trading Summary & High Accuracy Trade Alerts - newser.com
What momentum indicators show for Kura Oncology Inc. stockMarket Growth Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Can technical indicators confirm Kura Oncology Inc.’s reversalMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Understanding Kura Oncology Inc.’s price movement2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha
What drives Kura Oncology Inc stock priceGap Up/Gap Down Analysis & Tap Into the Fastest-Growing Companies - earlytimes.in
Is Kura Oncology Inc. showing signs of accumulationJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com
Kura Oncology Inc. stock momentum explained2025 AllTime Highs & Reliable Trade Execution Plans - newser.com
What analysts say about Kura Oncology Inc stockGap Up/Gap Down Analysis & Follow Top Performers in the Community - earlytimes.in
Can Kura Oncology Inc. stock resist market sell offs2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Kura Oncology (KURA) to Release Earnings on Thursday - MarketBeat
Can Kura Oncology Inc. stock rebound after recent weaknessJuly 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
1.71%
0.49%
자본화:
|
볼륨(24시간):